New Portfolio Positions: SAP and adidas

Magellan Investment Partners, recently recommended two new positions to the portfolio, both listed in Germany: SAP (SAP.ETR) and adidas (ADS.ETR). 

New Portfolio Positions: SAP and adidas

January 12, 2026
Magellan Investment Partners, recently recommended two new positions to the portfolio, both listed in Germany: SAP (SAP.ETR) and adidas (ADS.ETR). 
Read Transcript

One of our Core Fund Managers, Magellan Investment Partners (Magellan), recently recommended two new positions to the portfolio, both listed in Germany: SAP (SAP.ETR) and adidas (ADS.ETR). SAP provides enterprise software used to run core business operations, while adidas is a global sportswear company spanning performance and lifestyle products.

Magellan view SAP as an attractive long-term investment underpinned by i) significant revenue uplift as it transitions its customer base from on-premise to the cloud where it remains early in the journey, ii) the ability to sustain healthy revenue growth post this transition through innovation led price increases including AI functionality and continued cross-sell and upsell, and iii) healthy revenue growth and retiring of legacy products supporting meaningful margin expansion towards peer levels. Magellan think the market is currently providing an attractive entry point given a short-term focus on quarterly cloud revenue and backlog growth which is being negatively impacted by the heightened uncertainty earlier in the year around tariffs, US government spending cuts, and the broader macro environment. While not immune from the macro environment, Magellan largely view this as a pushout of customer migrations with limited implications for long-term profits and cashflows. SAP is also being impacted by software wide concerns around AI disruption which Magellan consider misplaced for SAP specifically.

Magellan view adidas as undervalued quality. adidas is a strong number two player in the sports & lifestyle footwear and apparel industry which grows above GDP. While a competitive industry that can see new entrants and impacts from fashion cycles, Magellan believe adidas’s brand, football heritage and scale enable it to remain an industry leader and has seen it take share over time and build a geographically diversified business. While less well positioned in the US given Nike’s dominance, the US is a small proportion of profits and more opportunity than threat. Near-term market concerns around macro conditions, a resurgent Nike, rising inventory levels, and ageing lifestyle products combined with conservative guidance, poor management communication, and looking back to 2022 issues have created in our opinion an attractive entry point. While some of these near-term concerns are warranted, Magellan believe they are more than fairly reflected in adidas’ share price, which combined with historically counter cyclical PEs provide downside protection should they occur and an attractive opportunity if they do not. adidas also has a strong balance sheet and is expected to start buying back its shares in 2026.

One of our Core Fund Managers, Magellan Investment Partners (Magellan), recently recommended two new positions to the portfolio, both listed in Germany: SAP (SAP.ETR) and adidas (ADS.ETR). SAP provides enterprise software used to run core business operations, while adidas is a global sportswear company spanning performance and lifestyle products.

Magellan view SAP as an attractive long-term investment underpinned by i) significant revenue uplift as it transitions its customer base from on-premise to the cloud where it remains early in the journey, ii) the ability to sustain healthy revenue growth post this transition through innovation led price increases including AI functionality and continued cross-sell and upsell, and iii) healthy revenue growth and retiring of legacy products supporting meaningful margin expansion towards peer levels. Magellan think the market is currently providing an attractive entry point given a short-term focus on quarterly cloud revenue and backlog growth which is being negatively impacted by the heightened uncertainty earlier in the year around tariffs, US government spending cuts, and the broader macro environment. While not immune from the macro environment, Magellan largely view this as a pushout of customer migrations with limited implications for long-term profits and cashflows. SAP is also being impacted by software wide concerns around AI disruption which Magellan consider misplaced for SAP specifically.

Magellan view adidas as undervalued quality. adidas is a strong number two player in the sports & lifestyle footwear and apparel industry which grows above GDP. While a competitive industry that can see new entrants and impacts from fashion cycles, Magellan believe adidas’s brand, football heritage and scale enable it to remain an industry leader and has seen it take share over time and build a geographically diversified business. While less well positioned in the US given Nike’s dominance, the US is a small proportion of profits and more opportunity than threat. Near-term market concerns around macro conditions, a resurgent Nike, rising inventory levels, and ageing lifestyle products combined with conservative guidance, poor management communication, and looking back to 2022 issues have created in our opinion an attractive entry point. While some of these near-term concerns are warranted, Magellan believe they are more than fairly reflected in adidas’ share price, which combined with historically counter cyclical PEs provide downside protection should they occur and an attractive opportunity if they do not. adidas also has a strong balance sheet and is expected to start buying back its shares in 2026.

Disclaimer: This material has been prepared by Hearts & Minds Investments, published on Jan 12, 2026. HM1 is not responsible for the content of linked websites or content prepared by third party. The inclusion of these links and third-party content does not in any way imply any form of endorsement by HM1 of the products or services provided by persons or organisations who are responsible for the linked websites and third-party content. This information is for general information only and does not consider the objectives, financial situation or needs of any person. Before making an investment decision, you should read the relevant disclosure document (if appropriate) and seek professional advice to determine whether the investment and information is suitable for you.

facebook
linkedin
All
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
November 7, 2023

Delve into the world of kids critical care and trauma research

In thie episode, we are joined by Dr. Marino Festa, or Rino for short. He is the Medical Director of NSW Kids ECMO Referral Service and a senior specialist in Paediatric Intensive Care at Children’s Hospital at Westmead.

Read More
impact-podcasts
October 31, 2023

Where Regal's Phil King is searching for opportunities

HM1's CIO, Charlie Lanchester, talks to Phil King of Regal Funds about his passion for stocks, his ongoing search for opportunities, and some of the sectors he’s excited by right now. Phil King of Regal Funds, has been a tremendous supporter of Hearts & Minds since the beginning.

Read More
investing
October 24, 2023

Preventing recurrent miscarriages and birth defects

In this episode, CEO Paul Rayson is joined by renowned biomedical researcher Professor Sally Dunwoodie. Prof. Dunwoodie's groundbreaking work has revolutionised clinical practices and enabled genetic diagnostic tests worldwide. In 2017, her team achieved a double breakthrough with the potential to prevent recurrent miscarriages and various birth defects.

Read More
impact-podcasts
October 17, 2023

Nick Griffin on how he finds global winners

In this episode, CIO Charlie Lanchester chats with Nick Griffin, the founding partner and CIO of Munro Partners, one of HM1's Core Fund Managers. They go over his career to date, reflect on the lessons he’s learned, and trace the decisions that led to him starting Munro.

Read More
investing
October 10, 2023

How A/Prof Matt Call is teaching our body to kill cancer

In this episode, CEO Paul Rayson is joined by WEHI’s Associate Professor Matt Call to talk about his incredible research. Matt’s team teaches and trains the body's own immune cells to target and kill cancer cells.

Read More
impact-podcasts
October 3, 2023

Understanding the 4 pillar framework underpinning a high conviction strategy

Listen to episode one with Chief Investment Officer Charlie Lanchester and TDM Growth Partners Investment Team Members Ed Cowan and Fraser Christie. They share their unique investment philosophies and delve into two high conviction stocks recommended for the HM1 portfolio.

Read More
investing
September 5, 2023

Recap on our Australian portfolio holdings

Off the back of reporting season, we have collated some feedback from our Fund Managers on some of the Australian listed companies in the HM1 portfolio.

Read More
April 10, 2023

Introducing our new Chief Investment Officer, Charlie Lanchester

We would like to introduce our new Chief Investment Officer, Charlie Lanchester. Charlie has significant funds management experience and thrilled to be joining the HM1 team.

Read More
November 11, 2022

Sohn Hearts & Minds with Nick Griffin and Maggie O'Neill

Maggie O'Neill, HM1's Head of Marketing and Operations joined Nick Griffin, CIO of Munro Partners to discuss Hearts & Minds' history, Munro Partners' involvement and Nick's upcoming stock pitch.

Read More
December 2, 2021

Hearts and Minds 2021: Buying is only half the battle

Patrick Poke from Livewire reviews some of the stocks held by HM1 and pitched at the 2020 Sohn Hearts & Minds Conference.

Read More
February 23, 2021

Podcast: Chris Cuffe, Inside the Rope

Get to know our Chairman. In this episode, Chris Cuffe shares his background in funds management, his current portfolio of roles and some of the key lessons he's learnt.

Read More
October 22, 2020

Equity Mates: Rory Lucas

Our CIO Rory Lucas recently sat down with the Equity Mates Podcast to talk all things Hearts and Minds.

Read More
September 18, 2020

Commsec Executive Series: Paul Rayson (HM1)

CEO Paul Rayson discusses our unique model on CommSec's Executive Series, highlighting our strong performance, support of Australian medical research, and our upcoming virtual conference on Nov 13.

Read More
July 21, 2020

Hearts and Minds but no ratings

HM1 CIO, Rory Lucas recently spoke with the Financial Standard about our 12-month performance and the challenges in receiving ratings from the major research houses.

Read More
May 18, 2020

What does NTA mean, and what's the difference between the 3 numbers?

We explain what NTA stands for, what it means for investors and what the difference between the three NTA numbers we publish.

Read More